These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15541630)

  • 1. Pharmacological management of challenging behavior of individuals with intellectual disability.
    McGillivray JA; McCabe MP
    Res Dev Disabil; 2004; 25(6):523-37. PubMed ID: 15541630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational use and rationale for use: psychiatric medication at an Argentine institution for intellectual disability.
    de Menil V; Cohen A
    Transcult Psychiatry; 2009 Dec; 46(4):651-71. PubMed ID: 20028682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of clozapine among individuals with intellectual disability: a review.
    Singh AN; Matson JL; Hill BD; Pella RD; Cooper CL; Adkins AD
    Res Dev Disabil; 2010; 31(6):1135-41. PubMed ID: 20692809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric disorders and behavior problems in people with intellectual disability.
    Myrbakk E; von Tetzchner S
    Res Dev Disabil; 2008; 29(4):316-32. PubMed ID: 17616450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic withdrawal-induced relapse predicts future relapses in institutionalized adults with severe intellectual disability.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychopharmacol; 2008 Aug; 28(4):401-5. PubMed ID: 18626266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ageing and mental health problems in people with intellectual disability.
    Torr J; Davis R
    Curr Opin Psychiatry; 2007 Sep; 20(5):467-71. PubMed ID: 17762589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric illness in mental retardation: an update on pharmacotherapy.
    Masi G; Luccherino L
    Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
    Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.